Statins use has been associated with reduced risk for developing orbitopathy among patients with Graves' disease. We hypothesize that statin reduces orbitopathy risk mainly by modulating both apoptosis and autophagy activities in patients with Graves' disease.
Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities / Bifulco, Maurizio; Ciaglia, Elena. - In: ENDOCRINE. - ISSN 1355-008X. - 53:(2016), pp. 649-650. [10.1007/s12020-015-0762-z]
Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities
Bifulco Maurizio;
2016
Abstract
Statins use has been associated with reduced risk for developing orbitopathy among patients with Graves' disease. We hypothesize that statin reduces orbitopathy risk mainly by modulating both apoptosis and autophagy activities in patients with Graves' disease.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
